
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
MARCKSL1 CRISPR/Cas9 KO Plasmid (h) | sc-403985 | 20 µg | $397.00 |
MARCKSL1 (MARCKS-like 1) encodes an actin-binding, membrane-associated protein that regulates cytoskeletal remodeling, cell shape, and motility through phosphorylation-dependent interactions with phospholipids and the actin network. It functions in processes linked to neurite outgrowth, cell migration, and adhesion dynamics, integrating signals downstream of kinases such as PKC and pathways controlling lamellipodia formation. Altered MARCKSL1 expression has been associated with changes in invasive behavior and proliferation programs in multiple tumor contexts, and it is also studied in neurodevelopmental biology where actin reorganization is critical. These properties make MARCKSL1 a useful node for dissecting actin-driven cellular phenotypes and signaling-to-cytoskeleton coupling.
MARCKSL1 CRISPR/Cas9 KO Plasmid (h) is a pool of plasmids designed for targeted disruption of the MARCKSL1 gene in human cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the MARCKSL1 together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the MARCKSL1 open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish MARCKSL1 protein expression.
This CRISPR knockout system enables efficient generation of MARCKSL1-deficient cell models for investigation of MARCKSL1 signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.